Alpha Cognition, Inc. (ACOG)
8.24
+0.09
(+1.10%)
USD |
NASDAQ |
Nov 06, 10:31
Alpha Cognition Enterprise Value : 136.02M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 136.02M |
| November 04, 2026 | 144.29M |
| November 03, 2026 | 137.10M |
| November 02, 2026 | 140.15M |
| October 30, 2026 | 148.86M |
| October 29, 2026 | 158.66M |
| October 28, 2026 | 158.23M |
| October 27, 2026 | 152.56M |
| October 26, 2026 | 139.28M |
| October 23, 2026 | 140.15M |
| October 22, 2026 | 139.50M |
| October 21, 2026 | 145.38M |
| October 20, 2026 | 146.03M |
| October 19, 2026 | 143.64M |
| October 16, 2026 | 136.89M |
| October 15, 2026 | 142.55M |
| October 14, 2026 | 146.90M |
| October 13, 2026 | 150.17M |
| October 12, 2026 | 151.04M |
| October 09, 2026 | 155.40M |
| October 08, 2026 | 155.40M |
| October 07, 2026 | 155.40M |
| October 06, 2026 | 154.09M |
| October 05, 2026 | 157.79M |
| October 02, 2026 | 156.70M |
| Date | Value |
|---|---|
| October 01, 2026 | 147.99M |
| September 30, 2026 | 154.52M |
| September 29, 2026 | 148.21M |
| September 28, 2026 | 145.81M |
| September 25, 2026 | 142.98M |
| September 24, 2026 | 145.16M |
| September 23, 2026 | 149.73M |
| September 22, 2026 | 153.44M |
| September 21, 2026 | 153.87M |
| September 18, 2026 | 150.82M |
| September 17, 2026 | 151.26M |
| September 16, 2026 | 141.46M |
| September 15, 2026 | 150.17M |
| September 14, 2026 | 148.21M |
| September 11, 2026 | 152.35M |
| September 10, 2026 | 152.35M |
| September 09, 2026 | 157.35M |
| September 08, 2026 | 165.85M |
| September 04, 2026 | 165.85M |
| September 03, 2026 | 159.10M |
| September 02, 2026 | 161.38M |
| September 01, 2026 | 158.23M |
| August 31, 2026 | 160.40M |
| August 28, 2026 | 158.01M |
| August 27, 2026 | 170.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.737B |
| Alnylam Pharmaceuticals, Inc. | 20.38B |
| Anika Therapeutics, Inc. | 245.53M |
| Savara, Inc. | 757.02M |
| Vericel Corp. | 2.582B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.790M |
| Revenue (Quarterly) | 6.093M |
| Total Expenses (Quarterly) | 14.88M |
| EPS Diluted (Quarterly) | -0.4037 |
| Gross Profit Margin (Quarterly) | 93.10% |
| Profit Margin (Quarterly) | -144.3% |
| Earnings Yield | -13.61% |
| Normalized Earnings Yield | -15.58 |